Irving Comprehensive Cancer Center, Columbia University Medical Center

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

Recurrent or Progressive Malignant Glioma

Studies at this site

• A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma — Completed